摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(pyridin-3-yl)-1-(thiophen-2-ylsulfonyl)-1,2,3,4-tetrahydroquinoline

中文名称
——
中文别名
——
英文名称
6-(pyridin-3-yl)-1-(thiophen-2-ylsulfonyl)-1,2,3,4-tetrahydroquinoline
英文别名
6-pyridin-3-yl-1-thiophen-2-ylsulfonyl-3,4-dihydro-2H-quinoline
6-(pyridin-3-yl)-1-(thiophen-2-ylsulfonyl)-1,2,3,4-tetrahydroquinoline化学式
CAS
——
化学式
C18H16N2O2S2
mdl
——
分子量
356.469
InChiKey
XWBRGTSOGHFBPD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    86.9
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    6-溴-1,2,3,4-四氢喹啉四(三苯基膦)钯 、 sodium hydride 、 sodium carbonate 作用下, 以 四氢呋喃乙二醇二甲醚 为溶剂, 反应 5.5h, 生成 6-(pyridin-3-yl)-1-(thiophen-2-ylsulfonyl)-1,2,3,4-tetrahydroquinoline
    参考文献:
    名称:
    Potent 11β-Hydroxylase Inhibitors with Inverse Metabolic Stability in Human Plasma and Hepatic S9 Fractions To Promote Wound Healing
    摘要:
    Topical application of CYP11B1 inhibitors to reduce cutaneous cortisol is a novel strategy to promote healing of chronic wounds. Pyridyl substituted arylsulfonyltetrahydroquinolines were designed and synthesized resulting in a strong inhibitor 34 (IC50 = S nM). It showed no inhibition of CYP17 and CYP19 and no mutagenic effects. It exhibited inverse metabolic stability in plasma (t(1/2) >> 150 mm), which is similar to wound fluid in composition, and in liver S9 fractions (t(1/2) = 16 mm).
    DOI:
    10.1021/jm501004t
点击查看最新优质反应信息

文献信息

  • Potent 11β-Hydroxylase Inhibitors with Inverse Metabolic Stability in Human Plasma and Hepatic S9 Fractions To Promote Wound Healing
    作者:Weixing Zhu、Qingzhong Hu、Nina Hanke、Chris J. van Koppen、Rolf W. Hartmann
    DOI:10.1021/jm501004t
    日期:2014.9.25
    Topical application of CYP11B1 inhibitors to reduce cutaneous cortisol is a novel strategy to promote healing of chronic wounds. Pyridyl substituted arylsulfonyltetrahydroquinolines were designed and synthesized resulting in a strong inhibitor 34 (IC50 = S nM). It showed no inhibition of CYP17 and CYP19 and no mutagenic effects. It exhibited inverse metabolic stability in plasma (t(1/2) >> 150 mm), which is similar to wound fluid in composition, and in liver S9 fractions (t(1/2) = 16 mm).
查看更多